Literature DB >> 31612560

Preimplantation genetic screening should be used in all in vitro fertilisation cycles in women over the age of 35 years: FOR: Optimising reproductive outcomes is cost-effective and minimises adverse sequelae.

Jara Ben Nagi1, Paul Serhal1, Dagan Wells2,3, Benjamin P Jones4,5.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31612560     DOI： 10.1111/1471-0528.15941

Source DB:  PubMed          Journal:  BJOG        ISSN： 1470-0328            Impact factor:   6.531


× No keyword cloud information.
  2 in total

1.  Live birth rate following a euploid blastocyst transfer is not affected by double vitrification and warming at cleavage or blastocyst stage.

Authors:  Efstathios Theodorou; Benjamin P Jones; Daniella F Cardenas Armas; Carleen Heath; Paul Serhal; Jara Ben-Nagi
Journal:  J Assist Reprod Genet       Date:  2022-02-26       Impact factor: 3.357

2.  Pre-implantation genetic testing for aneuploidy: motivations, concerns, and perceptions in a UK population.

Authors:  Benjamin P Jones; Timothy Bracewell-Milnes; Lorraine Kasaven; Ariadne L'Heveder; Megan Spearman; Diana Marcus; Maria Jalmbrant; Joy Green; Rabi Odia; Srdjan Saso; Paul Serhal; Jara Ben Nagi
Journal:  J Assist Reprod Genet       Date:  2021-03-11       Impact factor: 3.412
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.